The MassDevice Weekly Roundup brings you the latest medical device news and information.
FDA approves Boston Scientific’s Taxus Liberté Atom stent
The Food & Drug Administration approves the Natick stent pioneer’s small-vessel drug-eluting stent, clearing the way for it to hit the market next month. Read More
Inverness to partner with research institute to develop Alzheimer’s test
The Waltham diagnostics maker will fund R&D efforts for three years aimed at developing and commercializing a diagnostic test for Alzheimer’s disease discovered by researchers at the Blanchette Rockefeller Neurosciences Institute. Read More
Dr. Obama is in the house
More than $1 billion from the American Recovery and Reinvestment Act is earmarked for comparative effectiveness research. What will that mean for the Commonwealth’s medical device sector? Read More
MassDevice blog: The Obama imprint
Newly appointed officials, from leaders at the FDA to White House healthcare reform and budget czars, are already making their impacts felt in the healthcare sphere. Read More
Healthcare blog: Costs, costs, costs
Every week, veteran healthcare reporter Tinker Ready rounds up the latest news for MassDevice. This week, she takes a look at the impending collision between rising healthcare rolls and soaring costs in Massachusetts, a “drinking problem” at Harvard Medical School and a farewell to one of the last local docs to make house calls. Read More
Dollars & Spence: Why can’t I get funded?
Seven reasons your business plan isn’t getting traction with investors. Read More
Our weekly checkup takes the temperature of the 63 public medical device companies in the MassDevice Index. In addition to the index itself, which tracks the overall movement of the sector, we compare Monday morning’s opening share prices with their value when the markets close Friday afternoon and calculate the biggest gainers and losers. The checkup also takes a look at a different financial metric each week, ranking local players based on their performance in that category. This week we examine net profit margins, a calculation of net profit as a percentage of sales. Read More
This week, the Event Spotlight shines on The Medical Development Group‘s forum “Why devices fail and what you need to do to prevent it from happening,” slated for 5:30 p.m. June 3 at the Foley Hoag Emerging Enterprise Center, 1000 Winter Street, Waltham. Panelists Paul Nickelsberg of Orchid Technologies, Chase Sebor of Venture Technologies and Brian Stonecipher of Continuum will discuss the elements of successful medical device development. Browse the MassDevice Network
If you would like to subscribe to this newsletter, please visit our member registration page.
© 2009 Massachusetts Medical Devices Journal LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of MMDJ.